Evidence map›Paper›PMID 33098927›Full record

ArticleRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2020

Dose prediction with deep learning for prostate cancer radiation therapy: Model adaptation to different treatment planning practices.

Roya Norouzi Kandalan, Dan Nguyen, Nima Hassan Rezaeian, Ana M Barragán-Montero, Sebastiaan Breedveld, Kamesh Namuduri, Steve Jiang, Mu-Han Lin

Open access · greenAbstract read
In one paragraph

Article in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Roya Norouzi KandalanMedical Artificial Intelligence and Automation (MAIA) Laboratory, Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, USA; Department of Electrical Engineering, University of North Texas, Denton, USA.
Dan NguyenMedical Artificial Intelligence and Automation (MAIA) Laboratory, Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, USA.
Nima Hassan RezaeianDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA.
Ana M Barragán-MonteroMolecular Imaging, Radiotherapy and Oncology (MIRO), UCLouvain, Brussels, Belgium.
Sebastiaan BreedveldDepartment of Radiation Oncology, Erasmus University Medical Center - Cancer Institute, Rotterdam, The Netherlands.
Kamesh NamuduriDepartment of Electrical Engineering, University of North Texas, Denton, USA.
Steve JiangMedical Artificial Intelligence and Automation (MAIA) Laboratory, Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, USA. Electronic address: Steve.Jiang@UTSouthwestern.edu.
Mu-Han LinMedical Artificial Intelligence and Automation (MAIA) Laboratory, Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, USA. Electronic address: Mu-Han.Lin@UTSouthwestern.edu.
The University of Texas Southwestern Medical Center · USErasmus MC Cancer Institute · NLMemorial Sloan Kettering Cancer Center · USSouthwestern Medical CenterSouthwestern Medical Center · USUniversity of North Texas · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Elisa de Stanchina · 1985 to 2026
$347.4M
Intelligent treatment planning for cancer radiotherapyR01CA237269 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI JIA, XUN, JIANG, STEVE BIN · 2019 to 2023
$2.5M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA237269
6 · The paper itself

Abstract

purposeThis work aims to study the generalizability of a pre-developed deep learning (DL) dose prediction model for volumetric modulated arc therapy (VMAT) for prostate cancer and to adapt the model, via transfer learning with minimal input data, to three different internal treatment planning styles and one external institution planning style.

methodsWe built the source model with planning data from 108 patients previously treated with VMAT for prostate cancer. For the transfer learning, we selected patient cases planned with three different styles, 14-29 cases per style, in the same institution and 20 cases treated in a different institution to adapt the source model to four target models in total. We compared the dose distributions predicted by the source model and the target models with the corresponding clinical plan dose used for patient treatments and quantified the improvement in the prediction quality for the target models over the source model using the Dice similarity coefficients (DSC) of 0% to 100% isodose volumes and the dose-volume-histogram (DVH) parameters of the planning target volume and the organs-at-risk.

resultsThe source model accurately predicts dose distributions for plans generated in the same source style, but performs sub-optimally for the three different internal and one external target styles, with the mean DSC ranging between 0.81-0.94 and 0.82-0.91 for the internal and the external styles, respectively. With transfer learning, the target model predictions improved the mean DSC to 0.88-0.95 and 0.92-0.96 for the internal and the external styles, respectively. Target model predictions significantly improved the accuracy of the DVH parameter predictions to within 1.6%.

conclusionWe demonstrated the problem of model generalizability for DL-based dose prediction and the feasibility of using transfer learning to solve this problem. With 14-29 cases per style, we successfully adapted the source model into several different practice styles. This indicates a realistic way forward to widespread clinical implementation of DL-based dose prediction.

Indexed as

Deep LearningProstatic NeoplasmsRadiotherapy, Intensity-ModulatedHumansMaleRadiotherapy DosageRadiotherapy Planning, Computer-AssistedArtificial intelligenceDeep learningDose predictionProstateVMAT

Identifiers

PMID33098927
PMCPMC7908143
OpenAlexW3094541895

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.